Indapamide

CHEMBL406 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
365.8 g/mol
LogP
2.9
Phase
4

This thiazide-like diuretic is used to treat high blood pressure and fluid retention (edema) associated with heart failure. It reduces blood pressure by promoting sodium and water excretion in the kidneys, decreasing blood volume, and also by directly relaxing blood vessels. It is often preferred for hypertension due to its neutral effect on blood lipids and glucose.

分子量

365.8000 g/mol

LogP

2.90

TPSA

101.00 Ų

Lipinski 五规则

符合

治疗领域

作用机制

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

机制

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1

InChI

InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)

Molecular Formula

C16H16ClN3O3S

HBD / HBA

2 / 5

可旋转键数

3

重原子数

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

This thiazide-like diuretic is used to treat high blood pressure and fluid retention (edema) associated with heart failure. It reduces blood pressure by promoting sodium and water excretion in the kidneys, decreasing blood volume, and also by directly relaxing blood vessels. It is often preferred for hypertension due to its neutral effect on blood lipids and glucose.

Inhibits sodium reabsorption in the renal tubules, promoting excretion of sodium, chloride, and water. This reduces extracellular fluid volume and cardiac preload, lowering blood pressure.

Yes, Indapamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL406. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3702. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.